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Abstract
Background: This study aimed to prospectively evaluate the use of 3-dimensional printing 
(3DP) for the percutaneous transcatheter closure of a secundum atrial septal defect (ASD) with 
rim deficiency less than 5 mm.
Methods: Patients with ASD were scanned using multi-slice computed tomography to acquire 
raw data for virtual 3DP reconstruction models. Different ASD occluders were tried on the 3DP 
models to select the optimal size for intraoperative use. The patients were followed up 1 month 
postoperatively, and 3DP models were again manufactured to observe the operative effects.
Results: From January to April 2016, 6 patients (5 females and 1 male) were recruited. Their 
average age was 29.5 ± 17.6 years, and the mean ASD size was 13.4 ± 1.3 mm. ASD occlu-
sion succeeded in 5 of 6 cases. There were 1, 2, and 3 cases with 0-mm distance from the defect 
rim to the aorta, inferior vena cava, and superior vena cava, respectively. ASD occluder sizes 
were consistent between preoperative simulation and intraoperative placement in 4 cases. One 
case had occluder size change from 30 mm to 34 mm.
Conclusions: A 3DP model presents ASD in a more visible way and allows more direct pre-
operative simulation to choose the most appropriate size of occluder, as compared with conven-
tional imaging techniques. This technique is likely to extend the current indications for ASD 
with an insufficient rim. (Cardiol J 2016; 23, 6: 599–603)
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Introduction
Atrial septal defect (ASD) affects 0.88–3.89% 
of the total population and the incidence rate has 
increased over time [1]. Secundum ASD is lo-
cated in the fossa ovalis and surrounding area and 
accounts for 80% of ASD [2]. Although surgical 
closure has been the “gold standard” for ASD, 
percutaneous transcatheter closure remains the 
first choice for about 80% of secundum ASD with 
a stretched diameter < 38 mm and sufficient rim 
of 5 mm [3]. However, an insufficient rim less 
than 5 mm from the inferior vena cava (IVC), 
superior vena cava (SVC), and aorta remains 
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Conventional imaging techniques, such as 
echocardiography, computed tomography (CT), 
and magnetic resonance imaging provide valuable 
information for the preoperative evaluation of ASD, 
but may not be sufficient for optimal preoperative 
planning of complex ASD cases. Three-dimensional 
printing (3DP) is a novel technology that fabri-
cates a tactile object with raw materials through 
layer-by-layer deposition. 3DP has been used for 
preoperative evaluation and device development 
in orthopedics, plastic surgery, general surgery, 
and other areas [5–7]. However, no studies have 
reported to date using of 3DP for preoperative 
evaluation of ASD with defect rim less than 5 mm.
It was hypothesized that a 3DP heart model 
would aid in the percutaneous transcatheter clo-
sure of secundum ASD by allowing more precise 
demonstration of anatomical structures and more 
patient-specific preoperative simulation, as com-
pared with conventional 2-dimensional medical 
images. This article presents a preliminary study 
on 6 patients who had secundum ASD defect rim 
less than 5 mm from the IVC, SVC, or aorta.
Methods
This study was approved by the Institutional 
Review Board of Henan Provincial People’s Hos-
pital and is in compliance with the human research 
regulations stated in the Declaration of Helsinki.
Inclusion and exclusion criteria
A patient was included if the following criteria 
were satisfied: 1) they were capable of providing 
written informed consent; 2) color flow Doppler 
showed a distance from ASD rim to aorta, SVC, or 
IVC less than 5 mm, with a left-to-right shunt; and 
3) physical examination revealed systolic murmurs 
located between the second and third ribs to the 
left of the sternum. Exclusion criteria were severe 
kidney dysfunction or arrhythmias, such as atrial 
fibrillation or frequent premature contractions that 
were difficult to control at fewer than 70 bpm using 
medications, such as beta-blockers.
Computed tomography acquisition and  
three-dimensional virtual reconstruction
Before 64-slice CT (Siemens AG, Berlin, Ger- 
many), the patient was required to have a heart 
rate less than 70 bpm; otherwise, 25–50 mg me-
toprolol was given 1 h before scanning. Patients 
were placed in supine position with both hands 
beneath the head. Sagittal and coronal scans of the 
whole heart were first performed with the patient 
in inspiratory breath-hold. Then iopamidol 100 mL 
was intravenously injected at 5.0 mL/s through the 
median cubital vein with a saline chase of 15 mL 
at 5.0 mL/s. Images were acquired with a gantry 
rotation time of 0.35 s and tube current 200 mA at 
120 kV, with dose modulation of 75% of RR interval. 
All images were reconstructed with slice thickness 
of 0.625 mm at the workstation, and then saved in 
digital imaging and communications in medicine 
(DICOM) format.
The DICOM file was read into the Mimics 
17.0 software (Materialise NV, Leuven, Belgium). 
A mask was generated with the threshold of 
863–3,010 Hounsfield Units. Then the mask was 
regionally grown and edited to remove the non-
cardiac neighboring parts. The remaining cardiac 
mask was calculated for a 3D model that was later 
smoothed and saved in standard tessellation lan-
guage (.stl) format.
Three-dimensional printing
The .stl file was loaded into a ZRapid SLA450 
RAPID 3D printer (ZRapid Company, Jiangsu, 
China) and printed out with ZR80 photoreactive 
resin polylactic acid (ZRapid Company, Jiangsu, 
China) using stereolithography technique. Briefly, 
a helium-cadmium laser generator controlled by 
a computer emitted an ultraviolet beam to scan the 
fluid surface of a flume containing fluid photosensi-
tive resin in a dot-by-dot manner. As a result, the 
scanned region underwent a photopolymerization 
reaction and solidified in a few seconds to a thin 
layer. Then the work elevator moved down by 
1 mm so that the solidified layer was again im-
mersed in liquid resin. A milling cutter removed 
the redundant solidified resin and a new layer was 
solidified again following the above-mentioned 
steps, until the whole heart model was completely 
manufactured. The resolution of the printer was 
0.1 mm. Time of printing was mainly dependent 
on object size.
Preoperative simulation
We tried different sizes of ASD occluders on 
the 3DP heart model. An occluder was defined 
as “appropriate” if 1) had no compression on ad-
jacent tissues including the tricuspid valve, and 
2) did not obstruct the blood flow from SVC or IVC.
Operative protocols
Patients were placed in supine position and 
locally anesthetized with 1% lidocaine. After intra-
venous injection of 100 U/kg heparin, a Beijing ASD 
occluder (Starway Medical Technology, Inc., Bei-
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jing, China) was placed through a standard femoral 
venous sheath. The occluder was pushed and pulled 
several times to test its stability. The ASD occluder 
was then examined by chest radiography and bed-
side echocardiography to observe the morphology 
and position of the occluder. After the intervention, 
the puncture site was compressed with a sand 
bag for 4 h and the patient was required to remain 
at bed rest for 12 h. Postoperatively, the patient 
was intravenously injected with 400–500 IU/kg 
low-molecular-weight heparin every 12 h in two 
doses. Oral aspirin or clopidogrel were given for 
the first 6 months to prevent thrombosis.
Postoperative follow-up
One month postoperatively, the patients were 
re-examined by echocardiography and multi-slice 
computed tomography (MSCT). As mentioned 
above, the MSCT dataset was 3-dimensionally 
reconstructed, and then a 3DP heart model was 
produced for postoperative evaluation.
Statistical analysis
All data were processed using SPSS 19.0 
software (IBM Corporation, New York, US). Con-
tinuous data were expressed as mean ± standard 
deviation.
Results
From January to April 2016, 6 patients were 
recruited for our study. Eight heart models were 
generated using 3DP technology, including 2 post-
operative heart models.
Table 1 summarizes patient demographics, 
echocardiographic parameters, and occluder sizes 
during preoperative simulation and intraoperative 
placement. There were 5 females and 1 male. Their 
average age was 29.5 ± 17.6 years, ranging from 
8 to 50 years. The mean ASD size was 13.4 ± 1.3 mm. 
One patient had mixed ASD with 0 mm from the 
defect rim to the aorta and SVC. Two patients had 
0-mm distance from the defect rim to the IVC. 
Three patients had 0-mm distance from the defect 
rim to the aorta. The ASD occluder sizes were 
consistent in 4 of 6 cases. Case 2 was placed with 
a 34-mm ASD occluder, which was larger than 
the 30-mm occluder predicted by preoperative 
simulation. Case 3 had pulmonary vascular resist-
ance higher than 20 Wood Units during right heart 
catheterization and thus the interventional closure 
was discontinued. Pulmonary vasodilator therapy 
including sildenafil and bosentan was given to lower 
the pulmonary pressure.
Figure 1 shows the workflow to fabricate 
a 3DP heart model for preoperative simulation in 
the representative Case 1.
Discussion
The last decade has seen the development of 
3DP technology in cardiology. In 2006, Noecker et 
al. [8] first printed pediatric heart models using CT 
datasets and suggested that the 3D models were 
likely to aid in the placement of medical devices. 
Two years later, Kim et al. [9] employed 3DP mod-
els in the preoperative evaluation of ventricular 
septal defect, atrial septal defect, artificial mitral 
valve perivalvular leakage, and thoracic aortic 
pseudoaneurysm. In 2015, they reviewed their 
single-center experience using 3DP for preop-
erative evaluation and concluded that 3DP could 
reduce the mortality and morbidity of complicated 
cardiac surgeries [10]. None of these preliminary 
Table 1. Summary of patient characteristics and occluder size.
No. Age Sex ASD size 
[mm]
Distance [mm] Occluder size [mm]




1 11 Female 15.0 0 15.6 0 26 26
2 27 Female 14.5 33.5 0 16.0 30 34
3 34 Female 14.0 18.4 0 13.0 28 N/A*
4 47 Female 11.8 2.6 16.6 0 20 20
5 50 Female 13.0 8.3 19.0 0 24 24
6 8 Male 12.0 6.3 20.0 0 20 20
*Cardiac catheterization showed pulmonary vascular resistance higher than 20 Wood Units, and ASD closure was abandoned; AO — aorta; 
ASD — atrial septal defect; IVC — inferior vena cava; SVC — superior vena cava
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studies, however, have focused on the application 
of 3DP to ASD with insufficient defect rim near 
major blood vessels, including IVC, SVC, and aorta.
Results showed that it is feasible to employ 
3DP to optimize the choice of occluders for ASD 
with an insufficient defect rim. ASD occluders 
were successfully placed in 5 of 6 cases. The 
occluder sizes were consistent between preop-
erative simulation and intraoperative placement in 
4 of 6 cases. However, 2 cases with 0-mm distance 
from defect rim to IVC were not easily treated. 
Case 3 with pulmonary artery hypertension had 
a contraindication to closure. In case 2, the 30-mm 
ASD occluder was replaced by a 34-mm device. 
This was possibly the result of the weight of the 
ASD occluder, which slipped from the original site 
more easily when the IVC had no rim. Although 
Yan et al. [11] also demonstrated the feasibility of 
a 3DP heart model in a secundum ASD case with 
0-mm distance from defect rim to SVC and IVC.The 
results of this study indicated that the procedure 
may potentially have high risk, even with a 3DP 
heart model, since Case 2 was finally treated with 
a larger ASD occluder and Case 3 had an occluder 
contraindication.
Overall, the 3DP heart model presents a more 
visible and comprehensive 360-degree view for 
better understanding of cardiac anatomical struc-
tures (e.g., SVC, IVC, and aorta), allowing more 
effective and individualized preoperative plan-
ning by trying different sizes of ASD occluders 
preoperatively. 3DP technology is likely to reduce 
intraoperative time and postoperative complica-
tions, and increase success rates through a more 
efficient preoperative simulation. Some open heart 
surgeries for the repair of ASD may be avoided 
after a thorough preoperative evaluation to choose 
an appropriate occluder. It is currently difficult to 
define the exact indications for printing a heart 
model for preoperative planning. However, based 
on our experience, we propose the adoption of this 
technology for non-routine procedures after fully 
Figure 1. Workflow from echocardiographic evaluation to postoperative three-dimensional printing (3DP) assess-
ment; A. Preoperative color flow Doppler shows left-to-right shunt across the defect during systole; B. A 3DP heart 
model shows a mixed-type atrial septal defect (ASD) with 0-mm distance from defect rim to aorta and superior vena 
cava (SVC). Most cardiac anatomical structures, e.g., atrium, ventricle and interventricular groove, are shown in the 
3DP heart models, but it is noteworthy that no heart valves are demonstrated in the model; C. During preoperative 
simulation, a 26-mm ASD occluder was placed to completely cover the defect area without obvious obstruction of 
blood flow from major blood vessels including SVC, inferior vena cava (IVC), and aorta; D. A 26-mm ASD occluder 
was placed after only first attempt. An intraoperative push-and-pull test demonstrated good stability of the occluder; 
E. Postoperative multi-slice computed tomography showed no device misalignment or impingement on adjacent 
structures, e.g., aortic valves, SVC, or IVC; F. The postoperative 3DP heart model visually demonstrated the relation-
ship between the ASD occluder and adjacent structures. The ASD occluder completely covered the entire defect 
without impingement of adjacent tissues.
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discussing the details with the patient and obtain-
ing informed consent.
The current application of 3D printing in med-
icine is still limited by the following factors. First, 
the images acquired by CT or magnetic resonance 
imaging are not precise enough for 3DP, which has 
a minimum resolution of 0.01 mm. This problem 
may be resolved with the future development of 
medical imaging techniques. It was also noted 
that the 3DP heart model shows no heart valves, 
which might be due to its thinness and dynamic 
movements. Color Doppler is capable of showing 
both heart valves and blood flow, and thus may be 
integrated to improve the quality of images [12]. 
Second, the cost-effectiveness analysis should 
be taken into consideration when a cardiologist 
plans to use a 3DP heart model for preoperative 
simulation and postoperative evaluation. Patients 
have to pay extra not only for 3DP per se (200 to 
500 USD, depending on the materials and weight 
of the model), but also for preoperative and post-
operative MSCT scanning, as well as prolonged 
hospitalized stays. Situations still exist in which 
an experienced interventional cardiologist is 
capable of performing a successful operation in 
a complex case without the help of a 3DP heart 
model. Thus, the decision to print a heart model 
should be discussed with an experienced cardiolo-
gist and based on the patient’s ability to pay. 3DP 
may be more important for less experienced hos-
pitals and for more challenging cases, such as fe-
nestrated ASD with large atrial septal aneurysm. 
Third, since the research on the applications of 
3DP technology in clinical medicine is in its in-
fancy, most studies have been single case reports, 
which are insufficient to assess the actual effects 
of 3DP on prognosis and complications. Thus 
far, we have not observed any adverse events 
in the 5 cases implanted with an ASD occluder. 
A large-scale clinical trial with long-term follow-
up may reveal the positive or negative effects of 
3DP technology on patient survival.
Conclusions
In conclusion, the preliminary trials have 
demonstrated for the first time that 3DP is fea-
sible for preoperative planning of pediatric and 
adult ASD with insufficient defect rim less than 
5 mm from the SVC, IVC, or aorta. However, 
a randomized controlled trial with more patients is 
necessary to test whether or not 3DP technology 
helps to extend the indications for ASD in current 
guidelines.
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